Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroprocaine 1% and 2% for Peripheral Nerve Block in Pediatric Population
NCT03918798Phase 2Completed
- Sponsor
- Sintetica
- Start
- Feb 2019
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of chloroprocaine in inguinal hernia, pes planus, sponsored by Sintetica. Started Feb 2019; status: completed.
02
Drugs
chloroprocaine
03
Conditions
inguinal herniapes planus
Beyond the preview
Go deeper on NCT03918798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03918798.